• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在积极的尿毒症治疗开始前,通过光子吸收法评估的骨矿物质含量变化。

Changes in bone mineral content evaluated by photon absorptiometry before the start of active uremia treatment.

作者信息

Lindergård B

出版信息

Clin Nephrol. 1981 Sep;16(3):126-30.

PMID:7296969
Abstract

Bone mineral content (BMC) in the forearm was evaluated by photon absorptiometry in 74 out of 198 patients who were started on active uremia treatment between 1973 and 1979. The BMC was measured repeatedly up to 24 months prior to and 15 months after the start of regular hemodialysis (RDT). The mean change per month was -0.43% before the start and +0.08% after the start, showing that RDT patients have low BMC chiefly because they lose mineral before the start of active uremia treatment. Patients not given extra calcium and/or vitamin D seemed to lose mineral faster than those given this treatment. The mineral content was lower in patients with polycystic kidney disease than in patients with glomerulonephritis.

摘要

1973年至1979年间开始接受积极尿毒症治疗的198名患者中,74名患者的前臂骨矿物质含量(BMC)通过光子吸收法进行评估。在开始定期血液透析(RDT)前长达24个月以及开始后15个月期间,对BMC进行反复测量。开始前每月平均变化为-0.43%,开始后为+0.08%,这表明RDT患者的BMC较低主要是因为他们在积极尿毒症治疗开始前就失去了矿物质。未补充额外钙和/或维生素D的患者似乎比接受该治疗的患者矿物质流失更快。多囊肾病患者的矿物质含量低于肾小球肾炎患者。

相似文献

1
Changes in bone mineral content evaluated by photon absorptiometry before the start of active uremia treatment.在积极的尿毒症治疗开始前,通过光子吸收法评估的骨矿物质含量变化。
Clin Nephrol. 1981 Sep;16(3):126-30.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Bone mineral content in renal transplant patients.肾移植患者的骨矿物质含量
Clin Nephrol. 1978 Nov;10(5):196-200.
4
Persistence of diminished bone mineral content following renal transplantation in childhood.儿童肾移植后骨矿物质含量持续降低
Pediatrics. 1984 Apr;73(4):459-66.
5
Relations of bone mineral content, ash weight and bone mass: implication for correction of bone mineral content for bone size.
Clin Orthop Relat Res. 1980 Nov-Dec(153):241-7.
6
Monitoring of bone mineral content in patients on regular hemodialysis.
Nephron. 1989;52(2):158-61. doi: 10.1159/000185620.
7
Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.一项随机双盲安慰剂对照试验,旨在研究补充钙和维生素D对成年囊性纤维化患者骨矿物质密度和骨代谢的影响。
J Cyst Fibros. 2004 Dec;3(4):233-6. doi: 10.1016/j.jcf.2004.08.002.
8
Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.诺龙疗法对骨质疏松症患者前臂骨矿物质含量的影响。
Clin Orthop Relat Res. 1987 Dec(225):273-8.
9
Basal plasma levels of calcitonin and bone mineral mass in normal and uremic women. Effect of menopause.
Biomed Pharmacother. 1984;38(5):263-5.
10
In vivo bone mineral analysis throughout skeletal growth in rats: differences due to sex or vitamin D deficiency.
J Orthop Res. 1985;3(4):456-63. doi: 10.1002/jor.1100030408.